FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to FOLFOX
Related studies linked through entity extraction aliases.
Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer
- Status
- UNKNOWN
- Phase
- N/A
XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis
- Status
- COMPLETED
- Phase
- PHASE2
Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.
- Status
- TERMINATED
- Phase
- PHASE2
RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer
- Status
- COMPLETED
- Phase
- NA
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)
- Status
- COMPLETED
- Phase
- PHASE1
Neo-Adjuvant FOLFOX for Rectal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
- Status
- COMPLETED
- Phase
- PHASE2